These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17697143)

  • 1. Expression of the human Cathepsin L inhibitor hurpin in mice: skin alterations and increased carcinogenesis.
    Walz M; Kellermann S; Bylaite M; Andrée B; Rüther U; Paus R; Kloepper JE; Reifenberger J; Ruzicka T
    Exp Dermatol; 2007 Sep; 16(9):715-23. PubMed ID: 17697143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases.
    Bylaite M; Moussali H; Marciukaitiene I; Ruzicka T; Walz M
    Exp Dermatol; 2006 Feb; 15(2):110-8. PubMed ID: 16433682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis.
    Welss T; Sun J; Irving JA; Blum R; Smith AI; Whisstock JC; Pike RN; von Mikecz A; Ruzicka T; Bird PI; Abts HF
    Biochemistry; 2003 Jun; 42(24):7381-9. PubMed ID: 12809493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of hurpin (protease inhibitor 13): A new skin-specific, UV-repressible serine proteinase inhibitor of the ovalbumin serpin family.
    Abts HF; Welss T; Mirmohammadsadegh A; Köhrer K; Michel G; Ruzicka T
    J Mol Biol; 1999 Oct; 293(1):29-39. PubMed ID: 10512713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence, organization, chromosomal localization, and alternative splicing of the human serine protease inhibitor gene hurpin (PI13) which is upregulated in psoriasis.
    Abts HF; Welss T; Scheuring S; Scott FL; Irving JA; Michel G; Bird PI; Ruzicka T
    DNA Cell Biol; 2001 Mar; 20(3):123-31. PubMed ID: 11313015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin: overexpression and redistribution in psoriasis and cutaneous carcinomas.
    Moussali H; Bylaite M; Welss T; Abts HF; Ruzicka T; Walz M
    Exp Dermatol; 2005 Jun; 14(6):420-8. PubMed ID: 15885077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis.
    Schick C; Pemberton PA; Shi GP; Kamachi Y; Cataltepe S; Bartuski AJ; Gornstein ER; Brömme D; Chapman HA; Silverman GA
    Biochemistry; 1998 Apr; 37(15):5258-66. PubMed ID: 9548757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling.
    Tobin DJ; Foitzik K; Reinheckel T; Mecklenburg L; Botchkarev VA; Peters C; Paus R
    Am J Pathol; 2002 May; 160(5):1807-21. PubMed ID: 12000732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
    Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
    Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human cysteine protease cathepsin V can compensate for murine cathepsin L in mouse epidermis and hair follicles.
    Hagemann S; Günther T; Dennemärker J; Lohmüller T; Brömme D; Schüle R; Peters C; Reinheckel T
    Eur J Cell Biol; 2004 Dec; 83(11-12):775-80. PubMed ID: 15679121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
    Mustacich D; Wagner A; Williams R; Bair W; Barbercheck L; Stratton SP; Bhattacharyya AK; Powis G
    Carcinogenesis; 2004 Oct; 25(10):1983-9. PubMed ID: 15166090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition.
    Hwang SR; Stoka V; Turk V; Hook VY
    Biochemistry; 2005 May; 44(21):7757-67. PubMed ID: 15909990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of skin polyamines to the hairless phenotype in transgenic mice overexpressing spermidine/spermine N-acetyltransferase.
    Pietilä M; Parkkinen JJ; Alhonen L; Jänne J
    J Invest Dermatol; 2001 May; 116(5):801-5. PubMed ID: 11348473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular proliferation in mouse and human pancreatic islets is regulated by serpin B13 inhibition and downstream targeting of E-cadherin by cathepsin L.
    Lo CW; Kryvalap Y; Sheu TJ; Chang CH; Czyzyk J
    Diabetologia; 2019 May; 62(5):822-834. PubMed ID: 30824970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin L.
    Takeda A; Yamamoto T; Nakamura Y; Takahashi T; Hibino T
    FEBS Lett; 1995 Feb; 359(1):78-80. PubMed ID: 7851535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors.
    Carr TD; Feehan RP; Hall MN; Rüegg MA; Shantz LM
    Carcinogenesis; 2015 Apr; 36(4):487-97. PubMed ID: 25740823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
    Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
    Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of skin tumorigenesis in CD109-deficient mice.
    Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
    Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.